Kiavash Kiaee

Kiavash Kiaee


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Small
Verified
Journal Article
Closed access
PDF file
JLJunmin Lee
Junmin Lee
SMShreya Mehrotra
Shreya Mehrotra
EZElaheh Zare‐Eelanjegh
Elaheh Zare‐Eelanjegh
RRRaquel Rodrigues
Raquel Rodrigues
AAAlireza Akbarinejad
Alireza Akbarinejad
Su Ryon ShinSu Ryon Shin
Su Ryon Shin

13 August 2021 in Science Advances
Verified
Journal Article
Open access
MZMark M. Zaki
Mark M. Zaki
ELEmal Lesha
Emal Lesha
KSKhaled Said
Khaled Said
KKKiavash Kiaee
Kiavash Kiaee
LRLindsey Robinson-McCarthy
Lindsey Robinson-McCarthy
GCGeorge Church
George Church
Cell therapy has strong promise for treating COVID-19 survivors due to customizability, targetability, and regenerative function.

5 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
KKKiavash Kiaee
Kiavash Kiaee
YJYasamin A. Jodat
Yasamin A. Jodat
NBNicole J. Bassous
Nicole J. Bassous
NMNavneet Matharu
Navneet Matharu
Su Ryon ShinSu Ryon Shin
Su Ryon Shin
Experimental models of the central nervous system (CNS) are imperative for developmental and pathophysiological studies of neurological diseases. Among these models, three-dimensional (3D) induced pluripotent stem cell (iPSC)-derived brain organoid models have been successful in mitigating some of the drawbacks of 2D models; however, they are plagued by high organoid-to-organoid variability, making it difficult to compare specific gene regulatory pathways across 3D organoids with those of the native brain. Single-cell RNA sequencing (scRNA-seq) transcriptome datasets have recently emerged as powerful tools to perform integrative analyses and compare variability across organoids. However, transcriptome studies focusing on late-stage neural functionality development have been underexplored. Here, we combine and analyze 8 brain organoid transcriptome databases to study the correlation between differentiation protocols and their resulting cellular functionality across various 3D organoid and exogenous brain models. We utilize dimensionality reduction methods including principal component analysis (PCA) and uniform manifold approximation projection (UMAP) to identify and visualize cellular diversity among 3D models and subsequently use gene set enrichment analysis (GSEA) and developmental trajectory inference to quantify neuronal behaviors such as axon guidance, synapse transmission and action potential. We showed high similarity in cellular composition, cellular differentiation pathways and expression of functional genes in human brain organoids during induction and differentiation phases, i.e., up to 3 months in culture. However, during the maturation phase, i.e., 6-month timepoint, we observed significant developmental deficits and depletion of neuronal and astrocytes functional genes as indicated by our GSEA results. Our results caution against use of organoids to model pathophysiology and drug response at this advanced time point and provide insights to tune in vitro iPSC differentiation protocols to achieve desired neuronal functionality and improve current protocols.

31 August 2020
Verified
Book Chapter
Closed access
KKKiavash Kiaee
Kiavash Kiaee
YJYasamin A. Jodat
Yasamin A. Jodat
MMManu Sebastian Mannoor
Manu Sebastian Mannoor
Bioinspired Structures and Design - edited by Wole Soboyejo September 2020